Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (21-30 of 238) with videos related to

Pageof 24
Sort By:
BMJ Case Reports|March 5, 2026
Immune-mediated necrotising myopathy following semaglutide treatment: a contributing factor?Brian Lam, Eleni Tiniakou, Xinhai Robert Zhang, et al.
Rheumatic Diseases Clinics of North America|April 7, 2023
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?Madelon C Vonk, Shervin Assassi, Anna-Maria Hoffmann-Vold
Clinical & Developmental Immunology|January 16, 2013
Autoimmune disease geneticsTimothy B Niewold, George N Goulielmos, Mohammed Tikly, et al.
The Journal of Rheumatology|May 5, 2010
Association of RNA polymerase III antibodies with scleroderma renal crisisBinh Nguyen, Shervin Assassi, Frank C Arnett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2015
Anti-RNA Polymerase II Antibodies in a U.S. Cohort of Systemic Sclerosis Patients: Comment on the Article by Hamaguchi et alVeena Patel, Shervin Assassi, Maureen D Mayes, et al.
ACR Open Rheumatology|July 29, 2020
Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort StudyCarina Mihai, Rucsandra Dobrota, Shervin Assassi, et al.
Scientific Reports|December 28, 2024
Lack of association of the PLD4 SNP rs2841277 with systemic sclerosis in a European American populationYunqing Ma, Maureen D Mayes, Xinjian Guo, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Plos One|November 30, 2020
Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methodsXiao Xu, Meera Ramanujam, Sudha Visvanathan, et al.
Annals of the Rheumatic Diseases|May 16, 2024
Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosisMengqi Huang, Tracy Tabib, Dinesh Khanna, et al.
Pageof 24

Showing results (21-30 of 238) with videos related to

Sort By:
Pageof 24
BMJ Case Reports|March 5, 2026
Immune-mediated necrotising myopathy following semaglutide treatment: a contributing factor?Brian Lam, Eleni Tiniakou, Xinhai Robert Zhang, et al.
Rheumatic Diseases Clinics of North America|April 7, 2023
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?Madelon C Vonk, Shervin Assassi, Anna-Maria Hoffmann-Vold
Clinical & Developmental Immunology|January 16, 2013
Autoimmune disease geneticsTimothy B Niewold, George N Goulielmos, Mohammed Tikly, et al.
The Journal of Rheumatology|May 5, 2010
Association of RNA polymerase III antibodies with scleroderma renal crisisBinh Nguyen, Shervin Assassi, Frank C Arnett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2015
Anti-RNA Polymerase II Antibodies in a U.S. Cohort of Systemic Sclerosis Patients: Comment on the Article by Hamaguchi et alVeena Patel, Shervin Assassi, Maureen D Mayes, et al.
ACR Open Rheumatology|July 29, 2020
Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort StudyCarina Mihai, Rucsandra Dobrota, Shervin Assassi, et al.
Scientific Reports|December 28, 2024
Lack of association of the PLD4 SNP rs2841277 with systemic sclerosis in a European American populationYunqing Ma, Maureen D Mayes, Xinjian Guo, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Plos One|November 30, 2020
Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methodsXiao Xu, Meera Ramanujam, Sudha Visvanathan, et al.
Annals of the Rheumatic Diseases|May 16, 2024
Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosisMengqi Huang, Tracy Tabib, Dinesh Khanna, et al.
Pageof 24